NCT06589141View on ClinicalTrials.gov

Comparison Between Metformin and Glyburide in the Management of Gestational Diabetes

NANot yet recruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
Gestational Diabetes Mellitus in Pregnancy
Interventions
DRUG

MetFORMIN 500 Mg Oral Tablet

Metformin (500 to 2000 mg orally)

DRUG

GlyBURIDE 2.5 MG Oral Tablet

Glyburide (2.5 mg to 20 mg orally)

All Listed Sponsors
collaborator

Middle-Eastern College of Obstetricians and Gynecologists

OTHER

lead

Assiut University

OTHER